Subscribe Now Advertise

Categories

search Result

Avians High-Speed Clean Room Doors for Controlling Contamination

Clean rooms are critical in sectors such as pharmaceuticals, semiconductor fabrication, biotechnology, food processing, etc. In these industries, which are required to adhere to stringent contamination control standards, Avians high-speed clean room doors are emerging as a game-changing solution.Read more

JRS Pharma partner with Gujarat Microwax for cotton-based croscarmellose sodium plant

This manufacturing plant, is located in Mehsana and marks their fourth manufacturing facility in India.Read more

India’s pharma sector likely to double post US Biosecure Act

At present, China’s CDMO industry commands 8% global market share compared to India’s 2.7%. Read more

Decarbonising seven key MSME sectors could save Rs 370 million yearly

The study was conducted by the Centre for Study of Science, Technology and Policy (CSTEP).Read more

USFDA issues warning letter to Sun Pharma over manufacturing at Dadra facility

The warning letter summarises significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals at the facility.Read more

Temasek in talks to buy Rs 9 billion stake in medical equipment firm Tynor

The person further said that Temasek has bid for an up to 30-35% stake in the company for $100-120 million.Read more

60 pharma firms enrol under Centre’s scheme to upgrade manufacturing facilities

The scheme gives preference to micro, small and medium enterprises (MSMEs), supporting smaller players achieve high standards.Read more

CDSCO shuts down 36% of drug manufacturing units for failing quality standards

India has around 10,000 pharma manufacturing units, of which nearly 80 per cent are micro-small and medium-scale facilities. Read more

Indian pharmaceutical industry to expand by 9%; surpass $70 billion by FY27

Between FY13 and FY18, Indian pharma companies faced severe regulatory challenges that adversely impacted their operations and ability to launch new products in regulated markets. Read more

Increased scrutiny by US FDA: A boon or bane Indian pharmaceutical sector

Even with the surge in USFDA-approved manufacturing sites in India, the proportion of Official Action Initiated (OAI) observations by the USFDA has stayed consistent at 10% of total inspections in CY23. Read more

Hi There!

Now get regular updates from IPF Magazine on WhatsApp!

Click on link below, message us with a simple hi, and SAVE our number

You will have subscribed to our Industrial News on Whatsapp! Enjoy

+91 84228 74016